Why the study?
Does nebulized racemic epinephrine cause myocardial infarction in pediatric patients with croup syndrome?
Does nebulized racemic epinephrine cause myocardial infarction in pediatric patients with croup syndrome?
Nebulized racemic epinephrine, commonly used for severe respiratory distress in pediatrics, may cause myocardial infarction as a rare complication.
Answers are grounded in this paper and cite their sources.
Single case associates repeated nebulized racemic epinephrine with pediatric MI; hypothesis-generating and should not change practice.
Myocardial infarction is a previously unreported complication of treatment with racemic epinephrine that is used commonly in the emergency department for severe respiratory distress in bronchiolitis or croup syndrome. We describe a pediatric patient who presented with the croup syndrome and severe respiratory distress that required multiple doses of nebulized racemic epinephrine in the emergency department. The patient developed ventricular tachycardia and mild chest discomfort during one treatment, which resolved spontaneously on discontinuation of the nebulization. Persistently abnormal electrocardiograms and elevated creatine phosphokinase MB isoenzyme (CPK-MB) levels suggested a myocardial infarction had occurred. Subsequent echocardiography, cardiac catheterization, and angiography revealed an anatomically normal heart with normal coronary circulation; however, a stress nuclear study showed a small myocardial infarct. The significance of this previously unreported complication of racemic epinephrine is discussed, along with recommendations for proper use in the emergency department.
No takes yet. Share an insight, caveat, or question.
Butte et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: